Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
For the six months, sales was INR 191.07 million compared to INR 183.2 million a year ago. Revenue was INR 191.58 million compared to INR 191.02 million a year ago. Net income was INR 3.87 million compared to INR 11.44 million a year ago. Basic earnings per share from continuing operations was INR 0.24 compared to INR 0.7 a year ago. Diluted earnings per share from continuing operations was INR 0.24 compared to INR 0.7 a year ago.